Prevalence and clinical characteristics of children with medical complexity in Tottori Prefecture, Japan: A population-based longitudinal study.


Journal

Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 21 02 2020
revised: 15 06 2020
accepted: 16 06 2020
pubmed: 6 7 2020
medline: 3 7 2021
entrez: 6 7 2020
Statut: ppublish

Résumé

To investigate the prevalence and background of children with medical complexity (CMC) and its secular trend in Japan. CMC were defined as patients under the age of 20 years requiring medical care and devices. The patients were enrolled using the national health insurance claims data of three hospitals and two rehabilitation centers in Tottori Prefecture. The study period was divided into three periods: Period 1, 2007-2010; Period 2, 2011-2014; and Period 3, 2015-2018. A total of 378 CMC were enrolled. The prevalence of CMC was 1.88 per 1000 population among subjects aged <20 years in 2018, and it increased by approximately 1.9 times during the study period. The number of CMC who presented with severe motor and intellectual disabilities did not change from Period 1 to Period 3. Meanwhile, the number of CMC who had relatively preserved motor and intellectual abilities increased from 58 to 98. The proportion of CMC who required respiratory management and oxygen therapy increased by 1.3 and 1.8 times, respectively. By contrast, the proportion of CMC who need tube feeding decreased significantly between periods 1 and 3 (P < 0.05). The prevalence of CMC increased almost twice during the 12-year study period; however, the increase in the number of patients with relatively preserved motor and intellectual abilities was pronounced. This study showed that the need for medical care and devices differed based on the underlying disorders and severity of CMC; therefore, individualized medical, welfare, and administrative services and education about the various types of CMC must be provided.

Identifiants

pubmed: 32622762
pii: S0387-7604(20)30172-8
doi: 10.1016/j.braindev.2020.06.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

747-755

Informations de copyright

Copyright © 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Auteurs

Hiroyuki Yamada (H)

Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan. Electronic address: jms433b@hotmail.com.

Koyo Ohno (K)

Department of Pediatrics, Tottori Prefectural Rehabilitation Center for Children with Disabilities, Yonago, Japan.

Madoka Shiota (M)

Department of Pediatrics, Tottori Prefectural Rehabilitation Center for Children with Disabilities, Yonago, Japan.

Masami Togawa (M)

Department of Pediatrics, Tottori Prefectural Central Hospital, Tottori, Japan.

Yasushi Utsunomiya (Y)

Department of Pediatrics, Tottori Prefectural Central Hospital, Tottori, Japan.

Shinjiro Akaboshi (S)

Department of Pediatrics, Tottori Medical Center, Tottori, Japan.

Hirokazu Tsuchie (H)

Department of Pediatrics, Tottori Prefectural Central Hospital, Tottori, Japan; Department of Pediatrics, Tottori Prefectural Kousei Hospital, Kurayoshi, Japan.

Takayoshi Okada (T)

Department of Pediatrics, Tottori Prefectural Kousei Hospital, Kurayoshi, Japan.

Masayosi Oguri (M)

Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan; Clinical Examination Department, Faculty of Health Sciences, Kagawa Prefectural University of Health Sciences, Takamatsu, Japan.

Shigeru Higami (S)

Higami Ear-Nose-Throat, Snore and Sleep Clinic, Yonago, Japan.

Hisashi Noma (H)

Department of Data Science, The Institute of Statistical Mathematics, Tokyo, Japan.

Yoshihiro Maegaki (Y)

Division of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH